EVALUATION OF A NEW PROGESTIN

other public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-04 ⓘ

The provided text contains only the title "EVALUATION OF A NEW PROGESTIN" and lacks an abstract or additional content, making it impossible to summarize the study's specific findings or its relation to endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Contraceptive Agents Contraceptives, Oral Drug Therapy Endometriosis Ethinyl Estradiol Genital Diseases, Female Megestrol Menstruation Disturbances Progestins Toxicology Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-27T09:11:36.575535+00:00
pubmed
last seen: 2026-05-14T05:59:32.213054+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine